ReviewMolecular neurobiology2025
Trichloroethylene Exposure and Parkinson's Disease: Environmental Risk, Metabolic Pathways, and Mechanistic Insights.
Review in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Human Neurotoxicity of Trichloroethylene: A Biomarker Approach.Journal of applied toxicology : JAT · 2026Article
- Primary prevention of Parkinson's disease: proceedings, the 8C's and a position statement from the Parkinson's disease prevention think tank.NPJ Parkinson's disease · 2026Review
- The Green Parkinson's Belt: agricultural regions associated with increased Parkinson's disease burden in Mexico.Frontiers in aging neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Trichloroethylene (TCE) is a widely used industrial solvent noted for its environmental persistence and unique metabolic profile. In recent years, a growing body of epidemiological research and experimental models has implicated TCE exposure as a potential environmental risk factor in the development of Parkinson's disease (PD). TCE undergoes biotransformation primarily via cytochrome P450-mediated oxidation and glutathione conjugation. These pathways generate reactive metabolites capable of disrupting mitochondrial function, inducing oxidative stress, and activating neuroinflammatory cascades. These mechanisms are thought to contribute to the selective degeneration of dopaminergic neurons in the substantia nigra-a hallmark of PD. This review systematically evaluates the literature concerning the environmental distribution, metabolic fate, and exposure routes of TCE. It also synthesizes current evidence linking TCE-induced neurotoxicity to the pathogenesis of PD. Particular emphasis is placed on several key mechanistic insights, including α-synuclein aggregation, inhibition of mitochondrial complex I, and the roles of oxidative damage and neuroinflammation, offering a comprehensive perspective on the potential role of TCE in PD development. Moreover, the review addresses the methodological challenges associated with quantifying chronic low-level TCE exposure in human populations and underscores the need for long-term cohort studies to better assess the associated neurotoxic risks.
Indexed as
Identifiers
40614023What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.